CATX:NYSEAMERICAN
Perspective Therapeutics Inc
$2.76
arrow_upward
+1.47%(+0.040) 1D
Oct 2, 3:18:15 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CATX...
Open
$2.77
High
$2.82
Low
$2.68
Mkt. cap
315.06M
Avg. vol.
1.84M
Volume
1.79M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.84
Shares outstanding
114.15M
No. of employees
163
Open
$2.77
High
$2.82
Low
$2.68
Mkt. cap
315.06M
Avg. vol.
1.84M
Volume
1.79M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.84
Shares outstanding
114.15M
No. of employees
163
News stories
From web sources and news partners
Stock Titan
·
3 hours ago
A study of a targeted melanoma treatment will be presented at a cancer meeting in November.
TipRanks
·
22 hours ago
Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteperspectivetherapeutics.com